Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
WisdomTree International MidCap Dividend Fund
DIM
$169M
| $5.74M | ﹤0.01% |
107,243
-18,461
| -15% | -$940K |
|
|
CCXI
2502
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.74M | ﹤0.01% |
99,688
+66,615
| +201% | +$3.63M |
|
2503
iShares Core 10+ Year USD Bond ETF
ILTB
$596M
| $5.73M | ﹤0.01% |
76,451
-56,569
| -43% | -$4.14M |
|
2504
LeMaitre Vascular
LMAT
$2.42B
| $5.73M | ﹤0.01% |
217,099
+92,901
| +75% | +$2.43M |
|
2505
Wolverine World Wide
WWW
$1.59B
| $5.73M | ﹤0.01% |
240,690
-222,218
| -48% | -$4.51M |
|
|
EVBG
2506
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $5.73M | ﹤0.01% |
41,408
+4,311
| +12% | +$560K |
|
|
CCD
2507
Calamos Dynamic Convertible & Income Fund
CCD
$736M
| $5.73M | ﹤0.01% |
271,480
-77,948
| -22% | -$1.47M |
|
2508
CAE Inc. Common Shares
CAE
$8.62B
| $5.72M | ﹤0.01% |
353,613
-515,696
| -59% | -$7.98M |
|
|
DCPH
2509
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $5.72M | ﹤0.01% |
95,819
+68,317
| +248% | +$3.65M |
|
2510
First Trust Small Cap Value AlphaDEX Fund
FYT
$195M
| $5.72M | ﹤0.01% |
189,488
+59,212
| +45% | +$1.63M |
|
2511
Dine Brands
DIN
$442M
| $5.72M | ﹤0.01% |
135,768
+33,578
| +33% | +$1.36M |
|
2512
Scholar Rock
SRRK
$5.73B
| $5.69M | ﹤0.01% |
312,679
+103,575
| +50% | +$1.76M |
|
2513
iShares Global Consumer Discretionary ETF
RXI
$275M
| $5.68M | ﹤0.01% |
47,832
+3,557
| +8% | +$392K |
|
2514
Telefônica Brasil
VIV
$19.7B
| $5.68M | ﹤0.01% |
640,795
+313,060
| +96% | +$2.84M |
|
|
JPXN
2515
iShares JPX-Nikkei 400 ETF
JPXN
$137M
| $5.65M | ﹤0.01% |
95,155
-76,907
| -45% | -$4.4M |
|
2516
Ormat Technologies
ORA
$6.15B
| $5.65M | ﹤0.01% |
89,046
+50,217
| +129% | +$3.29M |
|
2517
CNA Financial
CNA
$14.3B
| $5.64M | ﹤0.01% |
175,392
+31,613
| +22% | +$973K |
|
2518
Innospec
IOSP
$2.14B
| $5.63M | ﹤0.01% |
72,951
+6,981
| +11% | +$510K |
|
|
TEAF
2519
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
| $5.63M | ﹤0.01% |
504,434
+75,133
| +18% | +$813K |
|
2520
Purple Innovation
PRPL
$42.4M
| $5.63M | ﹤0.01% |
12,503
+11,985
| +2,314% | +$3.78M |
|
|
CIR
2521
DELISTED
CIRCOR International, Inc
CIR
| $5.61M | ﹤0.01% |
220,344
+15,266
| +7% | +$238K |
|
|
SRNE
2522
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $5.61M | ﹤0.01% |
893,876
+767,420
| +607% | +$2.94M |
|
2523
Workiva
WK
$3.44B
| $5.6M | ﹤0.01% |
104,702
+71,009
| +211% | +$2.91M |
|
2524
First Trust Alerian Disruptive Technology Real Estate ETF
DTRE
$14.7M
| $5.59M | ﹤0.01% |
147,235
-59,151
| -29% | -$2.18M |
|
|
GUT
2525
Gabelli Utility Trust
GUT
$575M
| $5.59M | ﹤0.01% |
795,956
-19,021
| -2% | -$128K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.